Results 131 to 140 of about 147,902 (326)

Mechanoluminescence of Bi‐Activated NaYGeO4 Polycrystals and 3D Printed Scaffolds in the NUV/Blue and NIR Spectral Range

open access: yesAdvanced Optical Materials, EarlyView.
NUV/Blue and NIR emitting mechanoluminescent (ML) materials based on a Bi‐doped germanate compound (NYGOBx) are reported. 3D‐printing is used to fabricate complex scaffold devices from this material, suggested for use as mechanically‐activated light sources for functional illumination.
Hossein Ebrahim Hosseini   +5 more
wiley   +1 more source

PHOTODYNAMIC THERAPY IN THE TREATMENT OF PERIODONTAL DISEASE

open access: yesRomanian Journal of Medical and Dental Education, 2019
Biofilms that colonize tooth surfaces and epithelial cells lining the periodontal pocket ⁄ gingival sulcus (subgingival dental plaques) are among the most complex biofilms that exist in nature. Photodynamic therapy has been suggested as an alternative to
Maria-Alexandra Martu   +7 more
doaj  

Flexible and Water‐Resistant Y3Al5O12:Er3+/Yb3+ Upconversion Nanoparticles‐Based Luminescent Cellulose Paper for Anti‐Counterfeiting and VOCs Detection

open access: yesAdvanced Optical Materials, EarlyView.
This work presents a cost effective and sustainable approach of designing flexible, water resistant and bright green luminescent Y3Al5O12:Er3+/Yb3+ upconversion nanoparticles (UCNPs) incorporated into cellulose paper for anti‐counterfeiting and volatile organic compounds (VOCs) detection applications.
Annu Balhara   +5 more
wiley   +1 more source

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

open access: yesAdvanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar   +7 more
wiley   +1 more source

A High‐Fidelity RNA‐Targeting Cas13X Downregulates Connexin43 in Macroglia: A Novel Neuroprotective Strategy for Glaucoma

open access: yesAdvanced Science, EarlyView.
This study highlights the role of connexin43 (Cx43) in mediating glia activation and neuroinflammation in glaucoma. Using Cx43 knockout mice, it is shown that macroglial cells‐derived Cx43 modulates microglial activation, proliferation, migration, and polarization.
Guoli Zhao   +17 more
wiley   +1 more source

Recent Advances in mRNA Delivery Systems for Cancer Therapy

open access: yesAdvanced Science, EarlyView.
This review systematically investigates the applications of mRNA therapy in cancer treatment, with particular emphasis on nonviral delivery systems, targeting strategies, stimulus‐responsive systems, and local delivery methods. Concluding with a meticulous evaluation, the review sheds light on the prevailing challenges while illuminating promising ...
Zheng Zhang   +9 more
wiley   +1 more source

A Mitochondria‐Targeted Nanozyme Platform for Multi‐Pathway Tumor Therapy via Ferroptosis and Cuproptosis Regulation

open access: yesAdvanced Science, EarlyView.
This work reports a mitochondria‐targeted nanozyme platform, MIL‐Cu1.8S‐TPP/FA, which induces potent cuproptosis via localized delivery of Cu1.8S nanodots to mitochondria. Surface‐anchoring these nanodots onto MIL‐88B metal‐organic frameworks enhances both passive and active tumor targeting.
Chenguang Liu   +8 more
wiley   +1 more source

Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer

open access: yesAdvanced Science, EarlyView.
This review compares clinical outcomes, translational progress, and global funding trends across cancer phototherapies—photodynamic, photothermal, and photoimmunotherapy—and conventional immunotherapy. It highlights differences in treatment efficacy, clinical trial status, financial investment, and regulatory challenges, providing a comprehensive ...
Deepak S. Chauhan   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy